1. Mindel JS. Cholinergic pharmacology. In: Tasman W, Jaeger EA, eds. Duane's Foundations of Clinical Ophthalmology on CD-ROM. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.

2. Gabelt BT, Kiland JA, Tian B, et al. Aqueous humor: secretion and dynamics. In: Tasman W, Jaeger EA, eds. Duane's Foundation of Clinical Ophthalmology on CD-ROM. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.

3. Shields MB. Cholinergic agents. In: Shields' Textbook of Glaucoma. Philadelphia, PA: Lippincott Williams & Wilkins; 2005;501-508.

4. Bill A. Aqueous humor dynamics in monkeys (Macaca irus and Cercopithecus ethiops). Exp Eye Res. 1971;11:195-206.

5. Gabelt BT, Gottanka J, Lutjen-Drecoll E, et al. Aqueous humor dynamics and trabecular meshwork and anterior ciliary muscle morphologic changes with age in rhesus monkeys. Invest Ophthalmol Vis Sci. 2003;44:2118-2125.

6. Barany EH, Rohen JW. Localized contraction and relaxation within the ciliary muscle of the vervet monkey (Cercopithecus ethiops). In: Rohen JW, ed. The Structure of the Eye, Second Symposium. Stuttgart: FK Schattauer Verlag; 1965;287-311.

7. Rohen JW, Lutjen E, Baräny E. The relation between the ciliary muscle and the trabecular meshwork and its importance for the effect of miotics on aqueous outflow resistance. Albrecht von Graefes Arch Klin Exp Ophthalmol. 1967;172:23-47.

8. Bill A. Effects of atropine and pilocarpine on aqueous humour dynamics in cyno-molgus monkeys (Macaca irus). Exp Eye Res. 1967;6:120-125.

9. Rohen JW, Futa R, Lutjen-Drecoll E. The fine structure of the cribriform meshwork in normal and glaucomatous eyes as seen in tangential sections. Invest Ophthalmol Vis Sct. 1981;21:574-585.

10. Lutjen-Drecoll E, Futa R, Rohen JW. Ultrahistochemical studies on tangential sections of the trabecular meshwork in normal and glaucomatous eyes. Invest Ophthalmol Vis Sct. 1981;21:563-573.

11. Baräny EH. The immediate effect on outflow resistance of intravenous pilocarpine in the vervet monkey. Invest Ophthalmol. 1967;6:373-380.

12. Hart WM. Intraocular pressure. In: Hart WM, ed. Adler's Physiology of the Eye. 9th ed. St Louis, MO: Mosby; 1992;248-267.

13. Kaufman PL. Total iridectomy does not alter outflow facility responses to cyclic AMP in cynomolgus monkeys. Exp Eye Res. 1986;43:441-447.

14. Kaufman PL. Aqueous humor dynamics following total iridectomy in the cynomolgus monkey. Invest Ophthalmol Vis Sci. 1979;18:870-875.

15. Kaufman PL, Baräny EH. Loss of acute pilocarpine effect on outflow facility following surgical disinsertion and retrodisplacement of the ciliary muscle from the scleral spur in the cynomolgus monkey. Invest Ophthalmol. 1976;15:793-807.

16. Baräny E, Berrie CP, Birdsall NJM, et al. The binding properties of the muscarinic receptors of the cynomolgus monkey ciliary body and the response to the induction of agonist subsensitivity. Br J Pharmacol. 1982;77:731-739.

17. Erickson-Lamy KA, Polansky JR, Kaufman PL, et al. Cholinergic drugs alter ciliary muscle response and receptor content. Invest Ophthalmol Vis Sci. 1987;28:375-383.

18. Hubbard WC, Kee C, Kaufman PL. Aceclidine effects on outflow facility after ciliary muscle disinsertion. Ophthalmologica. 1996;210:303-307.

19. Shade DL, Clark AF, Pang IH. Effects of muscarinic agents on cultured human tra-becular meshwork cells. Exp Eye Res. 1996;62:201-210.

20. Erickson KA, Schreoder A. Direct effects of muscarinic agents on the outflow pathways in human eyes. Invest Ophthalmol Vis Sci. 2000;41:1743-1748.

21. Kiland JA, Hubbard WC, Kaufman PL. Low doses of pilocarpine do not significantly increase outflow facility in the cynomolgus monkey. Exp Eye Res. 2000;70: 603-609.

de Kater AW, Spurr-Michaud SJ, Gipson IK. Localization of smooth muscle myosin-containing cells in the aqueous outflow pathway. Invest Ophthalmol Vis Sci. 1990; 31:347-353.

de Kater AW, Shahsafaei A, Epstein DL. Localization of smooth muscle and non-muscle actin isoforms in the human aqueous outflow pathway. Invest Ophthalmol Vis Sci. 1992;33:424-429.

Flügel C, Tamm E, Lutjen-Drecoll E, et al. Age-related loss of a smooth muscle actin in normal and glaucomatous human trabecular meshwork of different age groups. J Glaucoma. 1992;1:165-173.

Lepple-Wienhues A, Stahl F, Wiederholt M. Differential smooth muscle-like contractile properties of trabecular meshwork and ciliary muscle. Exp Eye Res. 1991;53: 33-38.

Bershadsky AD, Balaban NQ, Geiger B. Adhesion-dependent cell mechanosensitivity. Ann Rev Cell Dev Biol. 2003;19:677-695.

Miotics. In: American Hospital Formulary Service Drug Information. Bethesda, MD: American Society of Health-System Pharmacists; 1998;2318-2328. Klein HZ, Lugo M, Shields MB, et al. A dose-response study of piloplex for duration of action. Am J Ophthalmol. 1985;99:23-26.

Goldberg I, Ashburn FS, Kass MA, et al. Efficacy and patient acceptance of pilocarpine gel. Am J Ophthalmol. 1979;88:843-846.

Johnson DH, Epstein DL, Allen RC, et al. A one-year multicenter clinical trial of pilocarpine gel. Am J Ophthalmol. 1984;97:723-729.

Lavin MJ, Wormald RP, Migdal CS, et al. The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol. 1990;108:1543-1548.

Sherwood MB, Grierson I, Millar L, et al. Long-term morphologic effects of anti-glaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients. Ophthalmology. 1989;96:327-335.

ntiglaucoma agents, cholinergic, long-acting. In: Drug Information for the Health Care Professional. Englewood, CO: Micromedix Inc; 1999;315-319. Lutjen E. Histometrische Untersuchungen über den Ziliarmuskel der Primaten. Albrecht von Graefes Arch Klin Exp Ophthalmol. 1966;171:121-133. Flügel C, Baräny EH, Lütjen-Drecoll E. Histochemical differences within the ciliary muscle and its function in accommodation. Exp Eye Res. 1990;50:219-226. Zhang X, Hernandez MR, Yang H, et al. Expression of muscarinic receptor subtype mRNA in the human ciliary muscle. Invest Ophthalmol Vis Sci. 1995;36:1645-1657. Gupta N, Drance SM, McAllister R, et al. Localization of M3 muscarinic receptor subtype and mRNA in the human eye. Ophthalmic Res. 1994;26:207-213. Gupta N, McAllister R, Drance SM, et al. Muscarinic receptor M1 and M2 subtypes in the human eye: QNB, pirenzipine, oxotremorine, and AFDX-116 in vitro autoradiography. Br J Ophthalmol. 1994;78:555-559.

Gil DW, Krauss HA, Bogardus AM, et al. Muscarinic receptor subtypes in human iris-ciliary body measured by immunoprecipitation. Invest Ophthalmol Vis Sci. 1997;38: 1434-1442.

Baräny EH. Dissociation of accommodation effects from outflow effects of pilocarpine. In: Paterson G, Miller SJH, Paterson GH, eds. Drug Mechanisms in Glaucoma. London: Churchill Ltd; 1966;275-282.

Croft MA, Oyen MJ, Gange SJ, et al. Aging effects on accommodation and outflow facility responses to pilocarpine in humans. Arch Ophthalmol. 1996;114:586-592.

Gabelt BT, Kaufman PL. Inhibition of outflow facility, accommodative, and miotic responses to pilocarpine in rhesus monkeys by muscarinic receptor subtype antagonists. J Pharmacol Exp Ther. 1992;263:1133-1139.

Gabelt BT, Kaufman PL. Inhibition of aceclidine-stimulated outflow facility, accommodation and miosis by muscarinic receptor subtype antagonists in rhesus monkeys. Exp. Eye Res. 1994;58:623-630.

Gil D, Spalding T, Kharlamb A, et al. Exploring the potential for subtype-selective muscarinic agonists in glaucoma. Life Sci. 2001;68:2601-2604. Bito LZ, Dawson MJ, Petrinovic L. Cholinergic sensitivity: normal variability as a function of stimulus background. Science. 1971;172:583-585.

Bito LZ, Hyslop A, Hyndman J. Antiparasympathomimetic effects of cholinesterase inhibitor treatment. J Pharmacol Exp Ther. 1967;157:159-169. Bito LZ, Banks N. Effects of chronic cholinesterase inhibitor treatment. I. The pharmacological and physiological behavior of the anti-ChE-treated (Macaca mulatta) iris. Arch Ophthalmol. 1969;82:681-686.

Bito LZ, Dawson MJ. The site and mechanism of the control of cholinergic sensitivity. J Pharmacol Exp Ther. 1970;175:673-684.

Claesson H, Baräny E. Time course of light-induced changes in pilocarpine sensitivity of rat iris. Acta Physiol Scand. 1978;102:394-398.

Kaufman PL, Baräny EH. Subsensitivity to pilocarpine of the aqueous outflow system in monkey eyes after topical anticholinesterase treatment. Am J Ophthalmol. 1976;82: 883-891.

Baräny E. Pilocarpine-induced subsensitivity to carbachol and pilocarpine of ciliary muscle in vervet and cynomolgus monkeys. Acta Ophthalmol. 1977;55:141-163. Kaufman PL. Anticholinesterase-induced cholinergic subsensitivity in primate accommodative mechanism. Am J Ophthalmol. 1978;85:622-631. Kaufman PL, Baräny EH. Subsensitivity to pilocarpine in primate ciliary muscle following topical anticholinesterase treatment. Invest Ophthalmol. 1975;14:302-306.

Lutjen-Drecoll E, Kaufman PL. Echothiophate-induced structural alterations in the anterior chamber angle of the cynomolgus monkey. Invest Ophthalmol Vis Sci. 1979;18:918-929.

Lutjen-Drecoll E, Kaufman P. Biomechanics of echothiophate-induced anatomic changes in monkey aqueous outflow system. Graefes Arch Clin Exp Ophthalmol. 1986;224:564-575.

Lindsey JD, Kashiwagi K, Kashiwagi F, et al. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism—implications for uveoscleral outflow. Surv Ophthalmol. 1997;41(suppl 2):S53-S59.

Patelska B, Greenfield DS, Liebmann JM, et al. Latanoprost for uncontrolled glaucoma in a compassionate case protocol. Am J Ophthalmol. 1997;124:279-286. Linden C, Alm A. Latanoprost and physostigmine have mostly additive ocular hypotensive effects in human eyes. Arch Ophthalmol. 1997;115:857-861. Bill A, Walinder P-E. The effects of pilocarpine on the dynamics of aqueous humor in a primate (Macaca irus). Invest Ophthalmol. 1966;5:170-175.

Poyer JF, Millar C, Kaufman PL. Prostaglandin F2a effects on isolated rhesus monkey ciliary muscle. Invest Ophthalmol Vis Sci. 1995;36:2461-2465. Anthony TL, Pierce KL, Stamer WD, et al. Prostaglandin F2a receptors in the human trabecular meshwork. Invest Ophthalmol Vis Sci. 1998;39:315-321.

62. Brown JH, Taylor P. Muscarinic receptor agonists and antagonists. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 2006;183-200.

63. Taylor P. Anticholinesterase agents. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 2006;201-216.

64. Stockdill P, Drance SM. Dose response of human intraocular pressure to various concentrations of echothiophate iodide. Trans Ophthalmol Soc U K. 1965;85:537-543.

65. Harris L. Dose-response analysis of echothiophate iodide. Arch Ophthalmol. 1971;86: 503-505.

0 0

Post a comment